Table 5.
Baseline characteristics of randomized participants
| Baseline characteristics |
Māori (n=257) |
Non-Māori (n=256) |
Total (n=513) |
|---|---|---|---|
| Number (%) or mean (SD) | |||
| Age (years)* |
59 (8) |
64 (8) |
62 (8) |
| Women* |
117 (46%) |
70 (27%) |
187 (36%) |
| History of CVD* |
83 (32%) |
150 (59%) |
233 (45%) |
| Coronary artery disease* |
60 (23%) |
126 (49%) |
186 (36%) |
| Cerebrovascular disease |
22 (9%) |
32 (13%) |
54 (11%) |
| Peripheral vascular disease |
9 (4%) |
10 (4%) |
19 (4%) |
| Diabetes* |
124 (48%) |
94 (37%) |
218 (42%) |
| Type 1* |
0 |
12 (5%) |
12 (2%) |
| Type 2* |
124 (48%) |
82 (32%) |
206 (40%) |
| Systolic blood pressure^ (mm Hg) |
142 (21) |
145 (19) |
144 (20) |
| Diastolic blood pressure^ (mm Hg)* |
85 (13) |
81 (11) |
83 (12) |
| Total cholesterol (mmol/l)* |
4.60 (0.96) |
4.21 (0.93) |
4.41 (0.97) |
| LDL cholesterol (mmol/l)* |
2.70 (0.85) |
2.38 (0.78) |
2.54 (0.83) |
| HDL cholesterol (mmol/l) |
1.14 (0.26) |
1.13 (0.30) |
1.14 (0.28) |
| Total:HDL cholesterol ratio* |
4.18 (1.08) |
3.86 (0.96) |
4.02 (1.05) |
| Triglycerides (mmol/l)* | 1.70 (0.76) | 1.54 (0.70) | 1.62 (0.73) |
*Difference between Māori and non-Māori statistically significant, p<0.05.
^Measured using an automated blood pressure monitor (Omron T9P).